Callan JMB (NASDAQ:CJMB) CEO Wayne Williams Buys 30,856 Shares

Callan JMB Inc. (NASDAQ:CJMB) CEO Wayne Williams bought 30,856 shares of the firm’s stock in a transaction that occurred on Thursday, December 11th. The stock was bought at an average price of $1.65 per share, with a total value of $50,912.40. Following the completion of the acquisition, the chief executive officer owned 68,545 shares of the company’s stock, valued at $113,099.25. This trade represents a 81.87% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Callan JMB Price Performance

CJMB stock opened at $1.78 on Friday. The firm has a market capitalization of $8.20 million and a P/E ratio of -1.43. The business’s 50-day moving average is $3.40 and its two-hundred day moving average is $4.38. Callan JMB Inc. has a 1 year low of $1.20 and a 1 year high of $7.76.

Callan JMB (NASDAQ:CJMB) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.61) EPS for the quarter. The company had revenue of $1.45 million for the quarter. Callan JMB had a negative return on equity of 133.43% and a negative net margin of 112.72%.

Hedge Funds Weigh In On Callan JMB

A hedge fund recently bought a new stake in Callan JMB stock. HighTower Advisors LLC acquired a new position in shares of Callan JMB Inc. (NASDAQ:CJMB) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 12,500 shares of the company’s stock, valued at approximately $56,000. HighTower Advisors LLC owned about 0.28% of Callan JMB at the end of the most recent quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Callan JMB in a research report on Monday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.